Innate Biologics Patents – Insights & Stats (Updated 2023)

Innate Biologics has a total of 12 patents globally, out of which no patent has been granted. Of these 12 patents, more than 83% patents are active. The United States of America and Hong Kong (S.A.R.) is where Innate Biologics has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Innate Biologics.

Innate Biologics was founded in 2016. Innate Biologics manages and shields against inflammation. They develop specialized, tissue-targeted anti-inflammatory medications for ailments and diseases that impact the digestive tract, brain, liver, kidneys, joints, skin, and tumour microenvironment.

Do read about some of the most popular patents of Innate Biologics which have been covered by us in this article and also you can find Innate Biologics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Innate Biologics patent portfolio.

How many patents does Innate Biologics have?

Innate Biologics has a total of 12 patents globally. These patents belong to 2 unique patent families. Out of 12 patents, 10 patents are active.

How Many Patents did Innate Biologics File Every Year?

Innate Biologics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantInnate Biologics Applications FiledInnate Biologics Patents Granted
20223
20211
20207
20191

How many Innate Biologics patents are Alive/Dead?

Worldwide Patents

Innate Biologics Patent Portfolio

How Many Patents did Innate Biologics File in Different Countries?

Innate Biologics Worldwide Patent Filing

Countries in which Innate Biologics Filed Patents

CountryPatent
United States Of America2
Hong Kong (S.A.R.)2
Europe1
Brazil1
Korea (South)1
Canada1
Australia1
China1

Where are Research Centers of Innate Biologics Patents Located?

The Research Centers of InnateBiologics Patents is the United States of America.

List of Innate Biologics patents

Innate Biologics PatentsTitle
US20220306702A1Methods And Compositions For Use Of Recombinant Bacterial Effector Proteins As Anti-Inflammatory Agents
US20220111017A1Immunomodulatory Compositions And Methods
EP3962512A4Immunomodulatory Compositions And Methods
CN114401730AImmunomodulatory Compositions And Methods
AU2020265755A1Immunomodulatory Compositions And Methods
CA3138860A1Immunomodulatory Compositions And Methods
HK40073765AImmunomodulatory Compositions And Methods
HK40070562AImmunomodulatory Compositions And Methods
KR1020220007619AImmunomodulatory Compositions And Methods
BR112021021839A2Immunomodulatory Compositions And Methods
WO2020223601A1Immunomodulatory Compositions And Methods
WO2019147988A1Methods And Compositions For Use Of Recombinant Bacterial Effector Proteins As Anti-Inflammatory Agents

What are Innate Biologics key innovation segments?

What Technologies are Covered by Innate Biologics?

The chart below distributes patents filed by Innate Biologics in different countries on the basis of the technology protected in patents. It also represents the markets where Innate Biologics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Innate Biologics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Innate Biologics?

Related Articles

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.